• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧对JAK2V617F阳性骨髓增殖性肿瘤CD34细胞中HIF-1α和NOS3表达的影响

Effect of hypoxia on HIF-1α and NOS3 expressions in CD34 cells of JAK2V617F-positive myeloproliferative neoplasms.

作者信息

Şoroğlu Can Veysel, Uslu-Bıçak İldeniz, Toprak Selin Fulya, Yavuz Akif Selim, Sözer Selçuk

机构信息

Department of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey; Institute of Health Sciences, Istanbul University, Istanbul, Turkey.

Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Istanbul University, Istanbul, Turkey.

出版信息

Adv Med Sci. 2023 Sep;68(2):169-175. doi: 10.1016/j.advms.2023.03.003. Epub 2023 Apr 17.

DOI:10.1016/j.advms.2023.03.003
PMID:37075583
Abstract

PURPOSE

Myeloproliferative neoplasms (MPN) are a heterogeneous group of hematopoietic stem-cell diseases with excessive proliferation of one or more blood cell lines. In this study, we evaluated the effect of different oxygen concentrations on HIF-1α and NOS3 gene expression to determine the effect of the bone marrow microenvironment on JAK2V617F positive Philadelphia chromosome negative (Ph) MPNs.

PATIENTS AND METHODS

Peripheral blood mononuclear cells (MNC) of 12 patients with Ph MPN were collected. The presence of JAK2V617F allele status was determined with allele-specific nested PCR analysis. MPN CD34 and CD34 populations were isolated from MNC by magnetic beads. Separate cell cultures of CD34 populations were managed at different oxygen concentrations including anoxia (∼0%), hypoxia (∼3%), and normoxia (∼20%) conditions for 24 ​h. HIF-1α and NOS3 gene expression changes were examined in each population related to JAK2V617F status with real time RT-PCR.

RESULT

It was revealed that relative HIF-1α and NOS3 expressions were significantly increased in response to decreased oxygen concentration in all samples. Relative HIF-1α and NOS3 expressions were found to be higher especially in CD34 and CD34 populations carrying JAK2V617F mutations compared to MPN patients carrying wild-type JAK2.

CONCLUSION

JAK2V617F might have specific role in HIF-1α and NOS3 regulations with respect to low oxygen concentrations in Ph MPN. Further evaluations might reveal the effect of JAK2V617F on Ph MPN pathogenesis in bone marrow microenvironment.

摘要

目的

骨髓增殖性肿瘤(MPN)是一组异质性造血干细胞疾病,其特征为一种或多种血细胞系过度增殖。在本研究中,我们评估了不同氧浓度对HIF-1α和NOS3基因表达的影响,以确定骨髓微环境对JAK2V617F阳性、费城染色体阴性(Ph)MPN的作用。

患者和方法

收集12例Ph MPN患者的外周血单个核细胞(MNC)。采用等位基因特异性巢式PCR分析确定JAK2V617F等位基因状态。通过磁珠从MNC中分离出MPN CD34⁺和CD34⁻群体。将CD34⁺群体的细胞分别在不同氧浓度下培养,包括缺氧(约0%)、低氧(约3%)和常氧(约20%)条件下培养24小时。采用实时RT-PCR检测每个群体中与JAK2V617F状态相关的HIF-1α和NOS3基因表达变化。

结果

结果显示,在所有样本中,随着氧浓度降低,HIF-1α和NOS3的相对表达显著增加。与携带野生型JAK2的MPN患者相比,尤其是携带JAK2V617F突变的CD34⁺和CD34⁻群体中,HIF-1α和NOS3的相对表达更高。

结论

在Ph MPN中,JAK2V617F可能在低氧浓度下对HIF-1α和NOS3的调节中发挥特定作用。进一步评估可能揭示JAK2V617F对骨髓微环境中Ph MPN发病机制的影响。

相似文献

1
Effect of hypoxia on HIF-1α and NOS3 expressions in CD34 cells of JAK2V617F-positive myeloproliferative neoplasms.缺氧对JAK2V617F阳性骨髓增殖性肿瘤CD34细胞中HIF-1α和NOS3表达的影响
Adv Med Sci. 2023 Sep;68(2):169-175. doi: 10.1016/j.advms.2023.03.003. Epub 2023 Apr 17.
2
Angiogenic factors are increased in circulating granulocytes and CD34 cells of myeloproliferative neoplasms.血管生成因子在骨髓增殖性肿瘤的循环粒细胞和CD34细胞中增加。
Mol Carcinog. 2017 Feb;56(2):567-579. doi: 10.1002/mc.22517. Epub 2016 Jul 8.
3
Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasms.缺氧诱导因子 1(HIF-1)是 JAK2V617F 阳性骨髓增殖性肿瘤的新治疗靶点。
Leukemia. 2020 Apr;34(4):1062-1074. doi: 10.1038/s41375-019-0629-z. Epub 2019 Nov 14.
4
Circulating CD133+/–CD34– Have Increased c- Expression in Myeloproliferative Neoplasms.循环 CD133+/–CD34– 在骨髓增生性肿瘤中具有更高的 c-表达。
Turk J Haematol. 2023 Feb 28;40(1):28-36. doi: 10.4274/tjh.galenos.2022.2022.0343. Epub 2022 Dec 2.
5
[Anti-angiogenic effect of interferon on JAK2V617F positive myeloproliferative neoplasms and its anti-angiogenic mechanisms].干扰素对JAK2V617F阳性骨髓增殖性肿瘤的抗血管生成作用及其抗血管生成机制
Zhonghua Yi Xue Za Zhi. 2015 Dec 8;95(46):3727-32.
6
Preferential nuclear accumulation of JAK2V617F in CD34+ but not in granulocytic, megakaryocytic, or erythroid cells of patients with Philadelphia-negative myeloproliferative neoplasia.在费城染色体阴性骨髓增殖性肿瘤患者的 CD34+细胞中,JAK2V617F 优先发生核积累,而在粒细胞、巨核细胞或红细胞中则不然。
Blood. 2010 Dec 23;116(26):6023-6. doi: 10.1182/blood-2010-08-302265. Epub 2010 Sep 22.
7
VEGF Regulation of Angiogenic Factors via Inflammatory Signaling in Myeloproliferative Neoplasms.血管内皮生长因子通过炎症信号在骨髓增殖性肿瘤中调节血管生成因子。
Int J Mol Sci. 2021 Jun 22;22(13):6671. doi: 10.3390/ijms22136671.
8
Hypoxia inhibits JAK2V617F activation via suppression of SHP-2 function in myeloproliferative neoplasm cells.低氧通过抑制骨髓增殖性肿瘤细胞中 SHP-2 的功能来抑制 JAK2V617F 的激活。
Exp Hematol. 2014 Sep;42(9):783-92.e1. doi: 10.1016/j.exphem.2014.05.007. Epub 2014 May 23.
9
[Progress of study on JAK2V617F mutation in myeloproliferative neoplasm].[骨髓增殖性肿瘤中JAK2V617F突变的研究进展]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Oct;19(5):1329-33.
10
miR-433 is aberrantly expressed in myeloproliferative neoplasms and suppresses hematopoietic cell growth and differentiation.miR-433 在骨髓增殖性肿瘤中异常表达,抑制造血细胞的生长和分化。
Leukemia. 2013 Feb;27(2):344-52. doi: 10.1038/leu.2012.224. Epub 2012 Aug 6.

引用本文的文献

1
Targeting PAR1 activation in JAK2V617F-driven philadelphia-negative myeloproliferative neoplasms: Unraveling its role in thrombosis and disease progression.靶向JAK2V617F驱动的费城阴性骨髓增殖性肿瘤中的PAR1激活:揭示其在血栓形成和疾病进展中的作用
Neoplasia. 2025 May;63:101153. doi: 10.1016/j.neo.2025.101153. Epub 2025 Mar 14.
2
GAPDH: unveiling its impact as a key hypoxia-related player in head and neck squamous cell carcinoma tumor progression, prognosis, and therapeutic potential.甘油醛-3-磷酸脱氢酶:揭示其作为头颈鳞状细胞癌肿瘤进展、预后及治疗潜力中关键的缺氧相关因子的影响。
Am J Cancer Res. 2023 Dec 15;13(12):5846-5867. eCollection 2023.